Canadian Association of Neurosciences Review: the role of dopamine receptor function in neurodegenerative diseases.
Dopamine (DA) receptors, which are heavily expressed in the caudate/putamen of the brain, represent the molecular target of several drugs used in the treatment of various neurological disorders, such as Parkinson's disease. Although most of the drugs are very effective in alleviating the symptoms associated with these conditions, their long-term utilization could lead to the development of severe side-effects. In addition to uncovering novel mediators of physiological DA receptor functions, recent research advances are suggesting a role of these receptors in toxic effects on neurons. For instance, accumulating evidence indicates that DA receptors, particularly D1 receptors, are central in the neuronal toxicity induced by elevated synaptic levels of DA. In this review, we will discuss recent findings on DA receptors as regulators of long term neuronal dysfunction and neurodegenerative processes.
Lebel
Manon
M
Neuroscience Research Group, Université du Québec à Trois-Rivières, Canada.
Robinson
Pierre
P
Cyr
Michel
M
D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000503:physiopathology; D003603:Cytotoxins / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000009:adverse effects; D006801:Humans; D009410:Nerve Degeneration / Q000378:metabolism / Q000503:physiopathology; D019636:Neurodegenerative Diseases / Q000378:metabolism* / Q000503:physiopathology; D018384:Oxidative Stress; D011954:Receptors, Dopamine / Q000378:metabolism*; D015398:Signal Transduction
D003603:Cytotoxins; D015259:Dopamine Agents; D011954:Receptors, Dopamine; D004298:Dopamine